Instrument Inactif

Autres langues SourcingLink.net, Inc. OTC Bulletin Board

Actions

US8361714053

Produits pharmaceutiques

Autres langues

07/10/24	Krystal Biotech, Inc. : ¿Subirá aún más?
02/10/24	Krystal Biotech, Inc. : Will it go even higher?
12/07/22	Oncology Pharma : Conducting Interviews and Presentations with Investors to Pursue Next Steps to Forward The Development Process of Nanoemulsion Drug Delivery System
29/06/22	Oncology Pharma : Conducting All The Preparations to Take Steps to Forward The Development Process of Nanoemulsion Drug Delivery System
06/06/22	Oncology Pharma : Financial Statements (Unaudited) for the year ended March 31, 2022
14/02/22	Oncology Pharma : Financial Statements for the period ended December 31, 2021
14/02/22	Oncology Pharma : Disclosure Statement for the period ended December 31, 2021
20/07/21	Oncology Pharma Inc :.
31/03/21	Oncology Pharma : Has Provided Initial Funding to NanoSmart Pharmaceuticals to Conduct Feasibility Studies for Initial Phases of IND-Enabling Activities
31/03/21	NanoSmart Pharmaceuticals, Inc. announced that it has received funding from Oncology Pharma Inc.
16/03/21	Oncology Pharma : Reveals Strategic Plans for Company Growth and Focus
10/03/21	Oncology Pharma : Vetting CROs to Develop Research Plan and Indications for Recently Licensed Cancer Combination Therapy
10/03/21	Oncology Pharma, Inc. Vetting CROs to Develop Research Plan and Indications for Recently Licensed Cancer Combination Therapy
04/03/21	Oncology Pharma : Moves to Fund Lead Drug Formulation & IND-Enabling Studies
04/03/21	Oncology Pharma Inc. Moves to Fund Lead Drug Formulation & IND-Enabling Studies
26/02/21	Oncology Pharma Signs Worldwide Licensing Agreement with Sybleu, Inc. for Commercialization of Chemotherapeutic Agent in Combination with a Bioactive Immunostimulatory Agent
26/02/21	Oncology Pharma Signs Worldwide Licensing Agreement with Sybleu, Inc. for Commercialization of Chemotherapeutic Agent in Combination with a Bioactive Immunostimulatory Agent
22/02/21	Oncology Pharma : Extends Licensing Agreement with NanoSmart Pharmaceuticals, Inc. for Veterinary Oncology
22/02/21	Oncology Pharma Extends Licensing Agreement with Nanosmart Pharmaceuticals, Inc. for Veterinary Oncology
16/02/21	Oncology Pharma : is Pleased to Welcome New Chairman to Its Scientific Advisory Board
16/02/21	Oncology Pharma Inc. Announces Henry Smith as New Chairman to Its Scientific Advisory Board
09/02/21	Oncology Pharma Renews Licensing Agreement with Ribera Solutions LLC for Its Connect2med Clinical Trials Platform
09/02/21	Oncology Pharma : Renews Licensing Agreement With Ribera Solutions LLC for Its Connect2Med Clinical Trials Platform
03/02/21	Oncology Pharma : Extends Its Licensing Agreement with NanoSmart Pharmaceuticals, Inc. for Human Oncology
29/01/21	Oncology Pharma Announces the Appointment Of New Chief Financial Officer